—

Elanco Animal Health (ELAN) — Technical state

As of 2026-11-04 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Signal: Recovery attempt under the 200-day — Trades +9.4% vs the 50-day and +6.4% vs the 200-day average, 9.5% below the 52-week high and +30.5% off the 52-week low; a death cross printed 24 sessions ago. Computed from daily closes. (as of 2026-11-04)
  • Trend: Elanco Animal Health trades 9.4% above its 50-day and 6.4% above its 200-day moving average. (as of 2026-11-04)

Elanco Animal Health makes medicines and preventive products for pets and farm animals, including flea and tick treatments, vaccines and pain therapies sold under brands such as Seresto and Galliprant. It also supplies feed additives and antibiotics for cattle, swine and poultry.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the ELAN overview. Research diary readings, not advice.

Recovery attempt under the 200-day

Trades +9.4% vs the 50-day and +6.4% vs the 200-day average, 9.5% below the 52-week high and +30.5% off the 52-week low; a death cross printed 24 sessions ago. Computed from daily closes.

The moving-average stack

FAQ · from the current data · as of 2026-11-04

Quick answers

What is the current Closelooknet signal on ELAN?

Recovery attempt under the 200-day — Trades +9.4% vs the 50-day and +6.4% vs the 200-day average, 9.5% below the 52-week high and +30.5% off the 52-week low; a death cross printed 24 sessions ago. Computed from daily closes. As of 2026-11-04; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is ELAN above its 50-day and 200-day moving averages?

As of 2026-11-04, Elanco Animal Health trades +9.4% above its 50-day and +6.4% above its 200-day average, with the 20-day +9.4% away.

How far is ELAN from its 52-week high?

9.5% below the 52-week high and 30.5% above the 52-week low, as of 2026-11-04.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.